Access Resources
871 - 880 of 7540 Results
Title
Year
- LUBAC assembles a ubiquitin signaling platform at mitochondria for signal amplification and transport of NF‐κB to the nucleus2022RESTRICTEDTitle: LUBAC assembles a ubiquitin signaling platform at mitochondria for signal amplification and transport of NF‐κB to the nucleusJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 41Issue #: 24Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.15252/embj.2022112006Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embj.2022112006Citation Count: 14
- Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy2022RESTRICTEDTitle: Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment StrategyJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 22Start Page: 14340End Page: 14340Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms232214340Best OA location URL: https://www.mdpi.com/1422-0067/23/22/14340/pdf?version=1669106553Citation Count: 7
- BDNF rs10501087, rs1491850 and rs11030094 polymorphisms associated with delayed progression in early-stage Parkinson's disease2022RESTRICTEDTitle: BDNF rs10501087, rs1491850 and rs11030094 polymorphisms associated with delayed progression in early-stage Parkinson's diseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.1053591Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.1053591/pdfCitation Count: 0
- Multi-platform proteomic analysis of Alzheimer’s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome2022RESTRICTEDTitle: Multi-platform proteomic analysis of Alzheimer’s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisomeJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-022-01113-5Best OA location URL: https://alzres.biomedcentral.com/counter/pdf/10.1186/s13195-022-01113-5Citation Count: 43
- Rehabilitation of Airway Protection in Individuals With Movement Disorders: A Telehealth Feasibility Study2022RESTRICTEDTitle: Rehabilitation of Airway Protection in Individuals With Movement Disorders: A Telehealth Feasibility StudyJournal Name: American Journal of Speech-Language PathologyPublisher: American Speech Language Hearing AssociationVol: 31Issue #: 6Start Page: 2741End Page: 2758Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1044/2022_ajslp-22-00063Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911128Citation Count: 4
-
RESTRICTEDTitle: Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammationJournal Name: Genome MedicinePublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13073-022-01132-9Best OA location URL: https://genomemedicine.biomedcentral.com/counter/pdf/10.1186/s13073-022-01132-9Citation Count: 5
-
RESTRICTEDTitle: Cell Biology of Parkin: Clues to the Development of New Therapeutics for Parkinson’s DiseaseJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 36Issue #: 12Start Page: 1249End Page: 1267Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40263-022-00973-7Citation Count: 5
-
RESTRICTEDTitle: Evaluation of Compensation Strategies for Gait Impairment in Patients With Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 20Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1212/wnl.0000000000201159Best OA location URL: https://n.neurology.org/content/neurology/99/20/e2253.full.pdfCitation Count: 6
- Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms2022RESTRICTEDTitle: Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanismsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-34667-xBest OA location URL: https://www.nature.com/articles/s41467-022-34667-x.pdfCitation Count: 70
- Altered Cortical Palmitoylation Induces Widespread Molecular Disturbances in Parkinson’s Disease2022RESTRICTEDTitle: Altered Cortical Palmitoylation Induces Widespread Molecular Disturbances in Parkinson’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 22Start Page: 14018End Page: 14018Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms232214018Best OA location URL: https://www.mdpi.com/1422-0067/23/22/14018/pdf?version=1668398534Citation Count: 7